An evaluation of the AccuCinch® Ventricular Restoration System in symptomatic heart failure patients with reduced ejection fraction (HFrEF)

Study Overview

  • Design: Prospective, randomized, open-label, multi-center, international, clinical safety and efficacy investigation
  • Randomization: Treatment with AccuCinch System plus guideline-directed medical therapy (GDMT) or GDMT alone
  • Enrollment: 400 randomized subjects at up to 80 centers worldwide

Key Eligibility Criteria:

  • Ejection Fraction ≥20% and ≤40%
  • New York Heart Association (NYHA) Classification:
    • NYHA II with a heart failure hospitalization in the past 12 months
    • NYHA III
    • NYHA IV ambulatory
  • LV end-diastolic diameter of ≥55 mm
  • Mitral Regurgitation ≤2+

Are you a candidate for the CORCINCH-HF Study?

  • Have you been told you have heart failure?
  • Has your doctor explained that you have reduced ejection fraction?
  • Are you taking heart failure medications, but your symptoms are worsening (e.g., shortness of breath, fatigue, coughing, leg swelling, or trouble breathing at night)?

If you have been diagnosed with heart failure and and answered “yes” to any of the questions above, you may be eligible to participate.  Talk to your physician or click the links below to learn more.

To Learn More